Yüklüyor......
First-Line Chemotherapy With Capecitabine and Temozolomide in Patients With Metastatic Pancreatic Endocrine Carcinomas
BACKGROUND: Temozolomide is an active agent in metastatic pancreatic endocrine carcinomas. In vitro data indicate that the combination of capecitabine and temozolomide is synergistic for induction of apoptosis in neuroendocrine tumor cell lines. The authors retrospectively evaluated the efficacy of...
Kaydedildi:
| Yayımlandı: | Cancer |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4665634/ https://ncbi.nlm.nih.gov/pubmed/20824724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25425 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|